Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer

Distant metastatic colorectal cancer (CRC) is present in approximately 25% of patients at initial diagnosis, and eventually half of CRC patients will develop metastatic disease. The 5-year survival rate for patients with metastatic CRC is a mere 12.5%; thus, there is an urgent need to investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekanem, Titus Ime, Tsai, Wei-Lun, Lin, Yi-Hsuan, Tan, Wan-Qian, Chang, Hsin-Yi, Huang, Tsui-Chin, Chen, Hsin-Yi, Lee, Kuen-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504004/
https://www.ncbi.nlm.nih.gov/pubmed/32842685
http://dx.doi.org/10.3390/molecules25173826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504004/
https://www.ncbi.nlm.nih.gov/pubmed/32842685
http://dx.doi.org/10.3390/molecules25173826

Ejemplares similares